N.J. MMJ Panel Says ‘Chronic Pain,’ Anxiety Should Qualify for Cannabis Recommendation

May 15, 2017

New Jersey took a big step toward approving several new conditions for medical marijuana on Thursday during a meeting of the state’s Medicinal Marijuana Review Panel in Trenton.

RELATED: Effort Supporting Legalization of Marijuana Launches in New Jersey

The panel voted that patients should be allowed to use medical marijuana if they suffer from “chronic pain” in connection with muscular skeletal disorders, as well as other conditions such as anxiety, irritable bowel syndrome and Tourette syndrome, NJ.com reported.

The panel voted against recommending that asthma and chronic fatigue qualify for medical marijuana, the report said.

Read more.